SANA Q1 2024 Earnings — Sana Biotechnology, Inc. Revenue & Financial Results | Market Cap Arena

SANASana Biotechnology, Inc.

$900M

Q1 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$111M

Net Income

-$107M

EPS (Diluted)

$-0.49

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$66M

Free Cash Flow

-$81M

Stock-Based Comp.

$9M

Balance Sheet

Total Assets

$681M

Total Liabilities

$306M

Stockholders' Equity

$375M

Cash & Equivalents

$177M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$111M	-$84M	-31.7%
Net Income	-$107M	-$82M	-30.9%